AREC — Arecor Therapeutics Share News
0.000.00%
- £14.35m
- £11.32m
- £5.05m
REG - Arecor Therapeutics - Arecor granted key patents in Europe and China
AnnouncementRCS - Arecor Therapeutics - Arecor presents positive data for AT247 at ADA
AnnouncementREG - Arecor Therapeutics - Exercise of rollover options & Total Voting Rights
AnnouncementREG - Arecor Therapeutics - Result of AGM
AnnouncementREG - Arecor Therapeutics - AGM Statement
AnnouncementREG - Arecor Therapeutics - Director/PDMR Shareholding
AnnouncementRCS - Arecor Therapeutics - TETRIS PHARMA LAUNCHES OGLUO® IN DENMARK & NORWAY
AnnouncementREG - Arecor Therapeutics - ARECOR 2022 ANNUAL REPORT AND NOTICE OF AGM
AnnouncementREG - Arecor Therapeutics - Arecor Granted Key U.S Patent
AnnouncementRCS - Arecor Therapeutics - Arecor on Investor Meet Company Platform
AnnouncementREG - Arecor Therapeutics - Unaudited Preliminary Results for 2022
AnnouncementREG - Arecor Therapeutics - Arecor Appoints Chief Business Officer
AnnouncementREG - Arecor Therapeutics - FIRST PATIENT DOSED IN AT278 CLINICAL TRIAL
AnnouncementREG - Arecor Therapeutics - Price Monitoring Extension
AnnouncementREG - Arecor Therapeutics - Price Monitoring Extension
AnnouncementREG - Arecor Therapeutics - Second Price Monitoring Extn
AnnouncementREG - Arecor Therapeutics - Price Monitoring Extension
AnnouncementREG - Arecor Therapeutics - Second Price Monitoring Extn
AnnouncementREG - Arecor Therapeutics - Price Monitoring Extension
Announcement